✦ LIBER ✦

Mechanisms of drug resistance to current and future antiviral therapies for hepatitis C virus infection

✍ Scribed by Jean-Michel Pawlotsky

Book ID: 107540381
Publisher: Current Science Inc.
Year: 2004
Tongue: English
Weight: 453 KB
Volume: 3
Category: Article
ISSN: 1540-3416
DOI: 10.1007/s11901-004-0007-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatitis C virus drug resistance and im

Hepatitis C virus drug resistance and immune-driven adaptations: Relevance to new antiviral therapy

✍ Silvana Gaudieri; Andri Rauch; Katja Pfafferott; Eleanor Barnes; Wendy Cheng; Ge 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 368 KB

The efficacy of specifically targeted anti-viral therapy for hepatitis C virus (HCV) (STAT-C), including HCV protease and polymerase inhibitors, is limited by the presence of drugspecific viral resistance mutations within the targeted proteins. Genetic diversity within these viral proteins also evol

Depression and antiviral response to int

Depression and antiviral response to interferon-based therapy for hepatitis C virus infection

✍ Jennifer M. Loftis; Benjamin J. Morasco; Peter Hauser 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 378 KB 👁 1 views

We read with great interest the article by Stepanova et al. 1 In this report from the United States with 10,582 eligible individuals (1.52% of whom were positive for hepatitis C virus [HCV] antibody [anti-HCV]), the rate of insurance coverage was significantly lower in patients with HCV infection (6

Suppressor of cytokine signaling 3 (SOCS

Suppressor of cytokine signaling 3 (SOCS3) expression and hepatitis C virus–related chronic hepatitis: Insulin resistance and response to antiviral therapy

✍ Marcello Persico; Mario Capasso; Eliana Persico; Monica Svelto; Roberta Russo; D 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 254 KB

Assessment of early virological response

Assessment of early virological response to antiviral therapy by comparing four assays for HCV RNA quantitation using the international unit standard: Implications for clinical management of patients with chronic hepatitis C virus infection

✍ Philippe Halfon; Guillaume Pénaranda; Marc Bourlière; Hacène Khiri; Marie-France 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 405 KB 👁 1 views

WHO International Standards for nucleic acid tests are used widely to compare the different assays used in HCV RNA quantitation. The aim of the study was to assess the impact of the international unit standard for measuring HCV RNA in the management of patients with chronic hepatitis C virus (HCV) i

Variants in interferon-alpha pathway gen

Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial

✍ Tania Mara Welzel; Timothy R. Morgan; Herbert L. Bonkovsky; Deepa Naishadham; Ru 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB 👁 2 views

Combination treatment with pegylated-interferon-alpha (PEG IFN-␣) and ribavirin, the current recommended therapy for chronic hepatitis C virus (HCV) infection, results in a sustained virological response (SVR) in only about half of patients. Because genes involved in the interferon-alpha pathway may

Predictive factors of virological non-re

Predictive factors of virological non-response to interferon–ribavirin combination therapy for patients infected with hepatitis C virus of genotype1b and high viral load

✍ Norio Akuta; Fumitaka Suzuki; Hitomi Sezaki; Yoshiyuki Suzuki; Tetsuya Hosaka; T 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 1 views

## Abstract Patients with high viral load (≥1.0 × 10^5^ IU/ml) of hepatitis C virus (HCV) genotype 1b do not achieve high sustained virological response rates to interferon (IFN)/ribavirin combination therapy. Previous studies suggested that pretreatment amino acid (aa) substitution patterns in the